A. Wygoda

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

How fast is repopulation of tumor cells during the treatment gap?

R. Tarnawski, Jack Fowler, Krzysztof Składowski et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 115 citations

Medicine, Cancer Biology, Oncology +14

DNA damage and repair in lymphocytes of normal individuals and cancer patients: studies by the comet assay and micronucleus tests.

Olena Palyvoda, Joanna Polańska, A. Wygoda et al. · Acta Biochimica Polonica · 2003 · 90 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer

Tomasz Rutkowski, Agnieszka Mazurek, Mirosław Śnietura et al. · Journal of Translational Medicine · 2020 · 75 citations · Full text

Medicine, Oncology, Chemotherapy +11

Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial

Krzysztof Składowski, B. Maciejewski, M. Goleń et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 73 citations

Medicine, Oncology, Radiation Oncology +9